Skip to content
Riskpilot
← Back to search
Sign in
Get full access
ISR Immune System Regulation Holding AB (publ)
AB
Bankrupt
Org 5590267828
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2015
6 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
ISR Immune System Regulation Holding AB (publ)
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
1M
1M
2M
2M
0M
2018
0M
2019
0M
2020
2M
2021
0M
2022
EBITDA
SEK millions
0M
-4M
-7M
-11M
-15M
-13M
2018
-20M
2019
-21M
2020
-16M
2021
-16M
2022
Income statement
SEK thousands
Item
2018
2019
2020
2021
2022
Revenue
0
105
136
2 287
0
Staff expenses
—
—
—
—
—
EBITDA
−12 950
−19 574
−20 948
−15 518
−16 470
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
−12 950
−19 574
−20 948
−15 518
−16 470
Net financials
−167
−10 060
−10 616
−75 055
−57 961
Profit before tax
−13 117
−29 634
−31 564
−90 573
−74 431
Tax
−0
−0
−0
−0
−0
Net profit
−13 117
−29 634
−31 564
−90 573
−74 431
Balance sheet
SEK thousands
Item
2018
2019
2020
2021
2022
Total assets
166 126
155 486
170 205
182 148
134 649
Equity
160 956
131 322
167 605
158 440
84 009
Long-term debt
0
0
0
1 014
1 014
Short-term debt
5 170
24 164
2 600
22 694
49 626
Total debt
5 170
24 164
2 600
23 708
50 640
Financial ratios
5-year trend
EBITDA margin
-1647000000.0%
This company
15.8%
Market median
-10424050733% vs market
2018
2022
Equity ratio
62.4%
This company
38.2%
Market median
+63% vs market
2018
2022
Return on equity
-88.6%
This company
18.4%
Market median
-582% vs market
2018
2022
Net profit margin
-7443100000.0%
This company
8.1%
Market median
-91890123557% vs market
2018
2022
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2018
2022
Debt / equity
0.60×
This company
0.62×
Market median
+3% vs market
2018
2022
Annual reports & filings
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
View
PDF
Annual report 2018
Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
View
PDF
More on ISR Immune System Regulation Holding AB (publ)
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
